Mergers and acquisitions

Less regulatory pressures, more growth: say top pharma execs

09-Jul-2012 - Pharma execs are now spending as much time dealing with increasing levels of regulations as they spend on growing their businesses, according to KPMG.

Bosch plans to upscale its new X-ray capsule QC tech

28-Jun-2012 - Bosch Packaging says it is now developing a big batch version of its new X-ray capsule inspection tech.

EXCLUSIVE

Pakistan's re-joined health ministry still troubled, says PPMA

27-Jun-2012 - PPMA is fearful that the Government of Pakistan’s recent call for more foreign investment in the local pharma sector will go unheard because the industry is already overcrowded.

Lack of “horsepower” prompts sale of AMPAC aerospace biz

06-Jun-2012 - AMPAC is selling its aerospace business after deciding it lacked the “horsepower” to grow both it and the pharmaceutical unit.

EXCLUSIVE

GDUFA means a level playing field for generics makers, says SOCMA

04-Jun-2012 - The new Generic Drugs User Fee Act (GDUFA) means a “level playing field” for drugmakers, according to SOCMA members.

Aptar to enter injectable device components with €165m buy

04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.

P-Gels mean cheaper and more varied drug development, says Patheon

31-May-2012 - Patheon says its new soft gel platform is creating cheaper development opportunities for drugsmakers.

Mergers a “key problem” for regulatory compliance, drug quality expert says

29-May-2012 - Biopharma mergers are a “key problem” for manufacturing quality teams as the loss of focus can lead to regulatory actions, a compliance expert said.

Manufacturing expansions round-up

12-Apr-2012 - in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans...

Cambrex on takeover hunt amid pharma fine chem consolidation

08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.

Danone and Mead Johnson to make united Pfizer nutrition bid?

27-Jan-2012 - Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.

Injectables maker NantWorks will give Pfizer's old Indiana facility an $85.5m makeover

12-Jan-2012 - NantWorks has unveiled plans to pump $85.5m into a new oncology and critical care injectables manufacturing plant in Terre Haute, Indiana.

Zhongxi Sunve buys stake in Chinese oncology API business

10-Jan-2012 - Zhongxi Sunve has bought a stake in a Chinese oncology API manufacturer and has further takeovers in the pipeline.

Rousselot buys Eastman Gelatine Corp in bid for pharma growth

09-Jan-2012 - Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.

Accelrys moves into Pharma QA/QC with VelQuest acquisition

05-Jan-2012 - R&D software firm Accelrys says it will speed up the pharma QA/QC process and reduce the compliance risk ten-fold through its $35m takeover of VelQuest.

Pall to buy ForteBio to build biopharma biz

22-Dec-2011 - Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.